A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Incyte Corporation
Incyte Corporation
Amgen
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Bayer
Novartis
Mabion SA
Hoffmann-La Roche
Celgene
Hoffmann-La Roche
Seagen Inc.
PharmaMar
Hoffmann-La Roche
Spectrum Pharmaceuticals, Inc
Celgene
Hoffmann-La Roche
Eli Lilly and Company
Hoffmann-La Roche
Eli Lilly and Company
Eisai Inc.
CTI BioPharma
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Chipscreen Biosciences, Ltd.
Hoffmann-La Roche
Takeda
Genentech, Inc.
Takeda
Teva Branded Pharmaceutical Products R&D, Inc.
Hoffmann-La Roche
Seagen Inc.
Genentech, Inc.
Presage Biosciences
Takeda
Hoffmann-La Roche
Sanofi
GlaxoSmithKline
Millennium Pharmaceuticals, Inc.
Shanghai CP Guojian Pharmaceutical Co., Ltd.
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service
Corixa Corporation